[1] Rudberg, S. and Osterby, R. (1998) Diabetic glomerulopathy in young IDDM patients, preventive and diagnostic aspects. Hormone Research, 50, 17-22. doi:10.1159/000053097
[2] Osterby, R. (1992) Glomerular structural changes in type 1 (insulin-dependent) diabetes mellitus: Causes, consequences, and prevention. Diabetologia, 35, 803-812. doi:10.1007/BF00399925
[3] Osterby, R. (1996) Lessons from kidney biopsies. Diabetes/Metabolism Reviews, 12, 151-174. doi:10.1002/(SICI)1099-0895(199610)12:3<151::AID-DMR162>3.0.CO;2-1
[4] Hishiki, T., Shirato, I., Takahashi, Y., Funabiki, K., Horikoshi, S. and Tomino, Y. (2001) Podocyte injury predicts prognosis in patients with IgA nephropathy using a small amount of renal biopsy tissue. Kidney & Blood Pressure Research, 24, 99-104. doi:10.1159/000054214
[5] Lemley, K.V., Lafayette, R.A., Safai, M., Derby, G., Blouch, A., Squarer, A. and Myers, B.D. (2002) Podocytopenia and disease severity in IgA nephropathy. Kidney International, 61, 1475-1485. doi:10.1046/j.1523-1755.2002.00269.x
[6] Macedo, C.S., Lerco, M.M., Capelletti, S.M., Silva, R.J., Pinheiro, D.O. and Spadella C.T. (2007) Reduction of podocytes number in late diabetic alloxan nephropathy: Prevention by glycemic control. Acta Cirurgica Brasileira, 22, 337-341. doi:10.1590/S0102-86502007000500003
[7] Kondo, K., Nozawa, K., Tomita, T. and Ezaki, K. (1957) Inbred strains resulting from Japanese mice. Bulletin of the Experimental Animals, 6, 107-112.
[8] Taketomi, S., Ikeda, H., Ishikawa, E. and Iwatsuka, H. (1982) Determination of overall insulin sensitivity in diabetic mice, KK. Hormone and Metabolic Research, 14, 14-18. doi:10.1055/s-2007-1018909
[9] Matsuo, T. and Shino, A. (1972) Induction of diabetic alterations by goldthioglucose-obesity in KK, ICR and C57BL mice. Diabetologia, 8, 391-397. doi:10.1007/BF01212165
[10] Shike, T., Gohda, T., Tanimoto, M., Funabiki, K., Horikoshi, S., Hirose, S., Shirai, T. and Tomino, T. (2005) Chromosomal mapping of a quantitative trait locus for the development of albuminuria in diabetic KK/Ta mice. Nephrology Dialysis Transplantation, 20, 879-885. doi:10.1093/ndt/gfh665
[11] Ito, T., Tanimoto, M., Matsumoto, M., Yamada, K., Kaneko, S., Msatsumoto, M., Obayashi, K., Hagiwara, S., Murakoshi, M., Aoki, T., Wakabayashi, M., Gohda, T., Funabiki, K., Maeda, K., Horikoshi, S. and Tomino, Y., (2006) Glomerular changes in the KK-Ay/Ta mouse: A possible model for human type 2 diabetic nephropathy. Nephrology, 11, 29-35. doi:10.1111/j.1440-1797.2006.00543.x
[12] Okazaki, M., Saito, Y., Udaka, Y., Maruyama, M., Murakami, H., Ota, S., Kikuchi, T. and Oguchi, K. (2002) Diabetic nephropathy in KK and KK-Ay mice. Experimental Animals, 51, 191-196. doi:10.1538/expanim.51.191
[13] Weibel, E.R. (1979) Stereological Methods: Practical Me- thods for Biological Morphometry. Academic Press, Inc., London.
[14] Cohen, M.P. and Ziyadeh, F. N. (1996) Role of amadori-modified nonenzymatically glycated serum proteins in the pathogenesis of diabetic nephropathy. Journal of the American Society of Nephrology, 7, 183-190.
[15] Fukami, K., Ueda, S., Yamagishi, S., Kato, S., Inagaki, Y., Takeuchi, M., Motoyama, Y., Bucala, R., Iida, S., Tamaki, K., Imaizumi, T. and Cooper, M.E. (2004) AGEs activate mesangial TGF-beta-smad signaling via an angiotensin II type I receptor interaction. Kidney International, 66, 2137-2147. doi:10.1111/j.1523-1755.2004.66004.x
[16] Pagtalunan, M.E., Miller, P.L., Jumping-Eagle, S., Nelson, R.G., Myers, B.D., Rennke, H.G., Coplon, N.S. and Meyer, T.W. (1997) Podocyte loss and progressive glomerular injury in type II diabetes. Journal of Clinical Investigation, 99, 342-348. doi:10.1172/JCI119163
[17] Lemley, K.V. (2008) Diabetes and chronic kidney disease: Lessons from the Pima Indians. Pediatric Nephrology, 23, 1933-1940. doi:10.1007/s00467-008-0763-8
[18] Asanuma, K., Campbell, K.N., Kim, K., Faul, C. and Mundel, P. (2007) Nuclear relocation of the nephrin and CD2AP-binding protein dendrin promotes apoptosis of podocytes. Proceedings of the National Academy of Sciences USA, 104, 10134-10139. doi:10.1073/pnas.0700917104
[19] Asanuma, K., Yanagida-Asanuma, E., Takagi, M., Kodama, F. and Tomino, Y. (2007) The role of podocytes in proteinuria. Nephrology, 12, 15-20. doi:10.1111/j.1440-1797.2007.00876.x
[20] Gu, L., Hagiwara, S., Fan, Q., Tanimoto, M., Kobata, M., Yamashita, M., Gohda, T., Ni, Z., Horikoshi, S. and Tomino, Y. (2006) Role of receptor for advanced glycation end-products-induced monocyte chemoattractant protein-1 expression in differentiated mouse podocytes. Nephrology Dialysis Transplantation, 21, 299-313. doi:10.1093/ndt/gfi210
[21] Nakamura, T., Ushiyama, C., Suzuki, S., Hara, M., Shimada, N., Ebihara, I. and Koide, H. (2000) Urinary excretion of podocytes in patients with diabetic nephropathy. Nephrology Dialysis Transplantation, 15, 1379-1383. doi:10.1093/ndt/15.9.1379
[22] Hara, M., Yanagihara, T., Takada, T., Itoh, M., Matsuno, M., Yamamoto, T. and Kihara, I. (1998) Urinary excretion of podocytes reflects disease activity in children with glomerulonephritis. American Journal of Nephrology, 18, 35-41. doi:10.1159/000013302
[23] Kretzler, M. (2005) Role of podocytes in focal sclerosis: Defining the point of no return. Journal of the American Society of Nephrology, 16, 2830-2832. doi:10.1681/ASN.2005080841
[24] Lemley, K.V., Lafayette, R.A., Safai, M., Derby, G., Blouch, K., Squarer, A. and Myers, B.D. (2002) Podocytopenia and disease severity in IgA nephropathy. Kidney International, 61, 1475-1485. doi:10.1046/j.1523-1755.2002.00269.x